Violencia en salud

Keyphrases

1. Lipid Profile 100%
2. Sacha Inchi 100%
3. Ethics 100%
4. Postpartum Contraception 100%
5. Norgestrel 100%
6. Hyperlipoproteinemia 100%
7. Psychiatry 100%
8. Mental Health 100%
9. Carbohydrate Metabolism 100%
10. Schizophrenia Spectrum Disorders 100%
11. Self-disorders 100%
12. Lima 100%
13. Stress Anxiety 100%
14. Stress-induced Depression 100%
15. Magistrates 100%
16. Peru 100%
17. Latin American 100%
18. American Perspective 100%
19. Person-centred Medicine 100%
20. Latin America (LATAM) 66%
21. Humanism 66%
22. Job Stress 60%
23. Corruption 50%
24. Glucose Utilization 50%
25. Normal Rate 50%
26. Human Economics 50%
27. Weight Gain 50%
28. Mental Disorders 50%
29. Contraceptives 50%
30. Insulin Sensitivity 50%
31. Glucose Load 50%
32. Peripheral Tissues 50%
33. Glucose Values 50%
34. Menstrual Cycle 50%
35. Human Development 50%
36. Economic Growth 50%
37. Health Concepts 50%
38. Third Countries 50%
39. Conceptual Differences 50%
40. Individual Person 50%
41. Underdevelopment 50%
42. Political Risk 50%
43. Psychiatric Problems 50%
44. Medical Specialties 50%
45. Poverty 50%
46. Moral 50%
47. Violence 50%
48. Mental Health Problems 50%
49. Published Data 50%
50. Cholesterol 40%
51. Non-esterified Fatty Acids 40%
52. District Attorney 40%
53. Job Anxiety 40%
54. Work-related Depression 40%
55. General Stress 40%
56. Judicial System 40%
57. Schizophrenia 33%
58. Well-being 33%
59. Clinical Evidence 33%
60. Consumption Goods 33%
61. Impact on Healthcare 33%
62. Distinctive Features 33%
63. Influence of Technology 33%
64. Human Being 33%
65. International College 33%
66. Healthy Individuals 33%
67. Technology Management 33%
68. Health Management 33%
69. Global Initiatives 33%
70. Secondary Effects 20%
71. Dyslipidemia 20%
72. Cholesterol HDL 20%
73. Triglyceride-glucose Index 20%
74. Hypercholesterolemia 20%
75. Insulin 20%
76. Randomized Clinical Trial 20%
77. Beneficial Effects 20%
78. Insulin Level 20%
79. Oil Intake 20%
80. Open Study 20%
81. Dosage Effect 20%
82. Effective Dose 20%
83. Instrument Validation 20%
84. Intervention Program 20%
85. Logistic Regression 20%
86. Informed Consent 20%
87. Preventive Intervention 20%
88. Transversal 20%
89. First-person Perspective 16%
90. People at Risk 16%
91. Early Therapy 16%
92. Schizophrenia Models 16%
93. First-year Experience 16%
94. Self-affection 16%
95. Evaluation Instrument 16%
96. Self-disturbance 16%
97. Psychotic 16%
98. Clinical Investigator 16%